GLP-1 agonists, such as Semaglutide or Tirzepatide, are used for weight management and treating type 2 diabetes, but certain conditions may disqualify someone from receiving these treatments
For patients trying to determine whether their specific medication was affected, this geographic information provides a starting point but not a definitive answer
Activation of Epac2 reduces the concentration of ATP required to achieve closure of K ATP channels promoting membrane depolarisation, Ca 2+ influx and subsequent Ca 2+ -induced Ca 2+ release from intracellular stores, insulin priming and finally insulin granule exocytosis (2931)
FIGURE 5 (B) Mechanisms of pyroptosis in diminished ovarian reserve
"Delayed Radionucleotide Gastric Emptying Studies Predict Morbidity in Diabetics With Symptoms of Gastroparesis"
JAMA Netw Open 5:e2231982